Zhejiang Yatai Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 234.14 million compared to CNY 218.22 million a year ago. Revenue was CNY 234.14 million compared to CNY 218.22 million a year ago.

Net loss was CNY 81.38 million compared to CNY 95.11 million a year ago. Basic loss per share from continuing operations was CNY 0.15 compared to CNY 0.18 a year ago. Diluted loss per share from continuing operations was CNY 0.15 compared to CNY 0.18 a year ago.